Cinepazet: Difference between revisions
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
No edit summary |
||
Line 24: | Line 24: | ||
| routes_of_administration = | | routes_of_administration = | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Cinepazet''' is a [[vasodilator]]. | '''Cinepazet''' is a [[vasodilator]]. | ||
==Synthesis== | |||
The synthesis of Cinepazet is carried out in two steps, starting with 3,4,5-Trimethoyxcinnamic acid reacting with SOCl<sub>2</sub> ([[thionyl chloride]]). The product, 3,4,5-Trimethoxycinnamoyl chloride is then reacted with ethyl piperazinoacetate and [[pyridine]]. | |||
==References== | |||
{{reflist|2}} | |||
{{Vasodilators used in cardiac diseases}} | {{Vasodilators used in cardiac diseases}} | ||
[[Category: | [[Category:Cardiovascular Drugs]] | ||
[[Category:Drug]] | |||
[[Category:Vasodilators]] | [[Category:Vasodilators]] | ||
Revision as of 21:35, 24 July 2014
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C20N2O6 |
Molar mass | 392.45 g/mol |
WikiDoc Resources for Cinepazet |
Articles |
---|
Most recent articles on Cinepazet |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Cinepazet at Clinical Trials.gov Clinical Trials on Cinepazet at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Cinepazet
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Cinepazet Discussion groups on Cinepazet Directions to Hospitals Treating Cinepazet Risk calculators and risk factors for Cinepazet
|
Healthcare Provider Resources |
Causes & Risk Factors for Cinepazet |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Cinepazet is a vasodilator.
Synthesis
The synthesis of Cinepazet is carried out in two steps, starting with 3,4,5-Trimethoyxcinnamic acid reacting with SOCl2 (thionyl chloride). The product, 3,4,5-Trimethoxycinnamoyl chloride is then reacted with ethyl piperazinoacetate and pyridine.
References
- Pages with script errors
- Pages using duplicate arguments in template calls
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Cardiovascular Drugs
- Drug
- Vasodilators